Help drive the research that can make a difference in your patients' lives

MIMS is currently working with our partners to identify doctors who are interested in becoming clinical study investigators for Real World Evidence studies. If you are interested, please click here or continue reading to find out more.

What is Real World Evidence?

Real World Evidence, which is based on data from routine clinical practice, can provide valuable insights and knowledge for physicians to support patient care. Although randomized clinical trials are the 'gold standard' of evidence-based medicine and feature highly controlled settings with predefined patient types and limited follow-up times, data from routine clinical practice generally involve varied medical settings with diverse patient populations.1 Both types of data are important and can be viewed as complementary, as they address different questions.

1. Nallamothu BK et al. Circulation 2008;118:1294–1303.

What are the benefits of Real World Evidence?

Real World Evidence studies benefit many different stakeholders: patients (in improving quality of care and treatment), physicians (by providing additional helpful information on the effectiveness and safety profiles of treatments as they are actually used) and payers (in supporting drug reimbursement, monitoring drug usage, and confirming cost-effectiveness).

What does it mean to participate in a Real World Evidence study?

As an investigator, you will lead the clinical investigation at your site, following the study protocol. Studies are conducted with approval from an Ethic Committee and in compliance with applicable regulations.

How do I become an investigator?

If you are interested to become a clinical study investigator for Real World Evidence studies, please click here or the button below to submit a short registration form to express your interest. We will then contact you and tell you about next steps.